Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Robert Saddawi‐Konefka"'
Autor:
Robert Saddawi-Konefka, Dan Kaufman, Shiqi Tang, Jiyoung Yun, Benjamin Goldenson, Riyam Al-Msari, Davide Bernareggi, Jaya L Thangaraj, Sonam H Patel, Sarah M Luna, J Silvio Gutkind
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Natural killer (NK) cells are key effector cells of antitumor immunity. However, tumors can acquire resistance programs to escape NK cell-mediated immunosurveillance. Identifying mechanisms that mediate this resistance enables us to define
Externí odkaz:
https://doaj.org/article/94b83004f91d40959f38c9c480b4ef73
Autor:
Olivia A. La Monte, Jason Han Lee, Shady I. Soliman, Robert Saddawi‐Konefka, Jeffrey P. Harris, Charles S. Coffey, Ryan K. Orosco, Deborah Watson, Michael A. Holliday, Farhoud Faraji, David B. Hom
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 8, Iss 5, Pp 1159-1168 (2023)
Abstract Objectives This study aimed to evaluate the outcomes of a hands‐on simulation‐based course with emphasis on procedural techniques, clinical reasoning, and communication skills developed to improve junior Otolaryngology – Head and Neck
Externí odkaz:
https://doaj.org/article/a771a9f3cb92432ab53613ebb9392437
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a8e837989d0f4abcaf12a1d26fe780d8
471 CD47 blockade as a targeted immune oncology agent in head and neck squamous cell carcinoma model
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f6b23ead8bb64ecc8a94a0c4ad540701
Autor:
Ezra Cohen, Robert Saddawi-Konefka, Andrew Sharabi, Joseph Califano, J Silvio Gutkind, Farhoud Faraji, Shiqi Tang, Riyam Al Msari, Lauren Clubb, Riley Jones
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9ddf2855f7ca419396c75ade81620735
Autor:
Robert Saddawi-Konefka, Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Shawn M. Jensen, Bryan S. Yung, Zhiyong Wang, Victoria H. Wu, Nana-Ama Anang, Riyam Al Msari, Shiruyeh Schokrpur, Ida Franiak Pietryga, Alfredo A. Molinolo, Jill P. Mesirov, Aaron B. Simon, Bernard A. Fox, Jack D. Bui, Andrew Sharabi, Ezra E. W. Cohen, Joseph A. Califano, J. Silvio Gutkind
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)
Response rates to immune checkpoint inhibitors (ICI) in patients with head and neck squamous cell carcinoma (HNSCC) remain low. Here the authors show that ablative treatment of tumor-draining regional lymphatics, a standard of care approach in patien
Externí odkaz:
https://doaj.org/article/45b1c1184762403b85513f3b2ecdf50e
Autor:
Zhiyong Wang, Yusuke Goto, Michael M. Allevato, Victoria H. Wu, Robert Saddawi-Konefka, Mara Gilardi, Diego Alvarado, Bryan S. Yung, Aoife O’Farrell, Alfredo A. Molinolo, Umamaheswar Duvvuri, Jennifer R. Grandis, Joseph A. Califano, Ezra E. W. Cohen, J. Silvio Gutkind
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
There is an unmet need to improve the response to immune checkpoint blockade in patients with head and neck squamous cell carcinoma (HNSCC). Here the authors show that aberrant HER3 activation sustains the proliferation of PIK3CA wild type HNSCC cell
Externí odkaz:
https://doaj.org/article/5c6d1bf166824a7299c38c08b6124d71
Autor:
Bernard Fox, Ezra Cohen, Shawn Jensen, Zhiyong Wang, Aaron Simon, Robert Saddawi-Konefka, Aoife O’Farrell, Andrew Sharabi, Joseph Califano, J Silvio Gutkind, Farhoud Faraji, Michael Allevato, Victoria Wu, Bryan Yung, Nana-Ama Anang, Ida Franiak-Pietryga
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2f0c2269e5b54e2e86880122aaa97157
Autor:
Robert Saddawi-Konefka, Aaron B. Simon, Whitney Sumner, Andrew Sharabi, Loren K. Mell, Ezra E. W. Cohen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Recent advancements in the development of immunotherapies have raised the hope for patients with locally-advanced HNSCC (LA-HNSCC) to achieve improved oncologic outcomes without the heavy burden of treatment-related morbidity. While there are several
Externí odkaz:
https://doaj.org/article/ecbe646215dc4931a88d3fef3682ecf4
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5289c166ce9242f38eeef62fac659de9